BBWI Bath & Body Works, Inc.
Retail-Retail Stores, NEC · NYSE · SEC CIK 701985 · Fiscal year ends 01/30
Financial factors as of 2026-08-01 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-2.2%
TTM net income YoY7.3%
TTM EPS YoY14.1%
Revenue 3-yr CAGR-1.1%
Net income 3-yr CAGR3.5%
Margins
Gross margin44.1%
Operating margin16.7%
Net margin10.8%
FCF margin14.3%
EBITDA margin20.2%
Returns
ROE—
ROA15.7%
ROIC (approx.)51.9%
Asset turnover1.45x
Leverage & solvency
Liabilities / assets120.4%
Debt / equity—
Current ratio1.20x
Interest coverage4.50x
Cash quality & payout
Operating cash flow / net income1.63x
Accruals ratio-9.9%
Payout ratio20.7%
Capex / revenue3.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252026-01-31 | FY20242025-02-01 |
|---|---|---|
| Income statement | ||
| Revenue | $7.29B | $7.31B |
| Cost of revenue | $4.10B | $4.07B |
| Gross profit | $3.19B | $3.23B |
| SG&A expense | $2.06B | $1.97B |
| Operating income | $1.13B | $1.27B |
| Interest expense | $276.00M | $312.00M |
| Pretax income | $882.00M | $1.03B |
| Income tax | $233.00M | $230.00M |
| Net income | $649.00M | $798.00M |
| EBITDA | $1.38B | $1.55B |
| EPS (basic) | 3.12 | 3.62 |
| EPS (diluted) | 3.11 | 3.61 |
| Dividends declared per share | 0.80 | 0.80 |
| Weighted avg. shares (diluted) | 209.00M | 221.00M |
| Balance sheet | ||
| Cash & equivalents | $953.00M | $674.00M |
| Receivables | $180.00M | $205.00M |
| Inventory | $699.00M | $734.00M |
| Current assets | $2.02B | $1.82B |
| PP&E, net | $1.13B | $1.13B |
| Goodwill | $628.00M | $628.00M |
| Total assets | $5.07B | $4.87B |
| Current liabilities | $1.59B | $1.23B |
| Short-term debt | $280.00M | $0 |
| Long-term debt | $3.61B | $3.88B |
| Total debt | $3.89B | $3.88B |
| Total liabilities | $6.35B | $6.25B |
| Shareholders' equity | -$1.28B | -$1.39B |
| Net debt | $2.94B | $3.21B |
| Shares outstanding | 201.00M | 216.00M |
| Cash flow statement | ||
| Operating cash flow | $1.10B | $886.00M |
| Capital expenditure | $237.00M | $226.00M |
| Free cash flow | $865.00M | $660.00M |
| Investing cash flow | -$227.00M | -$162.00M |
| Financing cash flow | -$599.00M | -$1.13B |
| Depreciation & amortization | $254.00M | $282.00M |
| Stock-based compensation | $31.00M | $40.00M |
| Dividends paid | $167.00M | $177.00M |
| Share buybacks | $401.00M | $401.00M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.